Intuitive Surgical, Inc. $ISRG Position Trimmed by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 456,858 shares of the medical equipment provider’s stock after selling 10,065 shares during the period. The Manufacturers Life Insurance Company owned about 0.13% of Intuitive Surgical worth $226,267,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG lifted its position in shares of Intuitive Surgical by 0.5% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock valued at $99,678,000 after acquiring an additional 883 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Intuitive Surgical by 14.9% in the 4th quarter. AQR Capital Management LLC now owns 33,592 shares of the medical equipment provider’s stock valued at $17,534,000 after acquiring an additional 4,365 shares in the last quarter. Kapitalo Investimentos Ltda purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $52,000. Finally, Becker Capital Management Inc. lifted its position in shares of Intuitive Surgical by 4.2% in the 4th quarter. Becker Capital Management Inc. now owns 591 shares of the medical equipment provider’s stock valued at $308,000 after acquiring an additional 24 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Up 0.6%

Shares of ISRG stock opened at $473.84 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market capitalization of $169.86 billion, a P/E ratio of 66.09, a P/E/G ratio of 4.94 and a beta of 1.59. The firm has a 50-day moving average price of $501.17 and a 200 day moving average price of $518.82.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period last year, the firm posted $1.78 EPS. The firm’s quarterly revenue was up 21.4% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. UBS Group increased their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Evercore ISI increased their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Finally, Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $595.95.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 7,893 shares of the business’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the completion of the transaction, the insider directly owned 13,187 shares of the company’s stock, valued at approximately $6,575,565.68. This represents a 37.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,839 shares of company stock valued at $7,896,972. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.